Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

a week ago

HOUSTON, Oct. 10, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc. ( NASDAQ:BPTH ) ( "Bio-Path" or the "Company" ) , a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today ...

Ticker	Sentiment	Impact
BPTH	Neutral	29 %